Welcome to our dedicated page for EMBX news (Ticker: EMBX), a resource for investors and traders seeking the latest updates and insights on EMBX stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect EMBX's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of EMBX's position in the market.
VanEck (EMBX) converted its VanEck Emerging Markets Bond mutual fund into the VanEck Emerging Markets Bond ETF (EMBX) effective October 6, 2025. The conversion was executed on a tax-free basis for existing shareholders and preserves the same investment objective, portfolio team and process.
Key metrics: 5‑year annualized return 4.9% vs benchmark 2.3%; team-managed assets ~$492.38M as of Sept 30, 2025; Class I expenses Gross 1.37%, Net 0.86% (contractual cap 0.85% until 05/01/2026).
